The characterization and purification of DNA binding proteins present within herpes simplex virus infected cells using monoclonal antibodies

Response of cultured Müller cells to heat shock--an immunocytochemical study of heat shock and intermediate filament proteins in response to temperature elevation

Müller cells from adult rabbit retina were cultured at normal (37 degrees C) temperature and under heat shock conditions (42-43 degrees C) for either 1.5 hr or 4 hr. The presence of heat shock proteins of three different molecular weights, and of vimentin, was identified by the use of monoclonal antibodies and of GFAP by a suitable polyclonal antibody coupled in each instance with immunofluorescence microscopy or immuno-electron microscopy. Heat shock conditions resulted in the expression of HSP of molecular weights in the ranges 57-61 kD, 68 kD and 90 kD. The high level of expression of GFAP in unshocked Müller cell cultures (80-90% of cells) was reduced after 1.5 hr of heat shock to 20-30% of cells, and after 4 hr to only 5%. Although the expression of vimentin (90% of untreated cells) was only slightly reduced by heat shock (60-80% of cells) the intracellular staining pattern of vimentin was greatly altered by heat shock. Changes in the expression of HSP, GFAP and vimentin can all be regarded as part of the Müller cell response to heat shock conditions.

Stress proteins accumulate in cultured retinal glial cells during herpes simplex viral infection

The production of stress- or heat-shock proteins (SP) which are defined by three monoclonal antibodies (TI56, TG5E and TG7A) were examined in cultured retinal glial cells with and without herpes simplex virus (HSV) infection. Indirect immunofluorescence showed that 80-90% of uninfected cells reacted with anti-glial fibrillary acidic protein (GFAP) and that 10-20% of uninfected cells were weakly labelled with anti-SP antibodies. By 6 hr after HSV infection, the proportion of GFAP labelled cells decreased to 60-70% whereas cells strongly expressing SP antigens were demonstrated. At 24 hr, GFAP+ cells were markedly reduced in number and immunolabelling with anti-SP antibodies was evident in approximately 50% of cells, directly demonstrating the accumulation of SP in cultured retinal cells after HSV infection. Double labelling with GFAP/TI56 indicated that 30% of GFAP+ cells were labelled with TI56 and 30-50% of TI56+ cells were also GFAP+, despite the abrupt loss of GFAP+ cells during HSV infection. These results indicate that SP normally expressed at low level are significantly upregulated in retinal glial cells following HSV infection.

Interactions between herpes simplex virus and murine bone marrow macrophages

Macrophages from murine bone marrow (strain C3Hf Bu/Kam) were cultured in vitro in L-cell conditioned medium. After 0, 2, 4, 6, 8 and 10 days, they were infected with a clinical strain of herpes simplex virus type 1 and the outcome followed morphologically, by phagocytic index, infectious virus yields, immunofluorescence, expression of Fc receptors and major histocompatibility complex (MHC) Class II antigens. At a multiplicity of infection of 1-5, little morphological difference was apparent between infected and uninfected cultures at early stages in vitro but marked changes occurred later with reduction in cell numbers in the infected cultures. Indirect immunofluorescence failed to detect cells expressing early viral antigens, and yields of infectious virus indicated that permissive infection was not taking place. While phagocytic index and Fc receptor expression did not change 24 hours post-infection, MHC Class II antigen expression was increased. Thus, although the bone marrow macrophages seem predominantly resistant to infection with HSV-1, they may be modified by the presence of the virus. Since macrophages may act as antigen presenting cells for the immune system, this type of mechanism may be important in the generation of local immune responses.

Typing and subtyping of herpes simplex isolates by monoclonal fluorescence

The type specificity of 16 herpes simplex monoclonal antibodies was tested on 50 isolates previously typed by endonuclease restriction. A panel of antibodies was selected and used to type isolates from 50 primary and 50 recurrent genital infections. Sixty-four isolates from 18 patients followed up for six months were subtyped by using a larger panel of monoclonal antibodies and predominant HSV1 and HSV2 subtypes were demonstrated. In addition to confirming recurrences, four possible reinfections were identified. Type-specific differences in the location of viral antigens in infected cells were noted and a possible association of this finding with the type-specific differences in rates of recurrence of genital infections discussed.

Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection

Three herpes simplex virus type I (HSV-I) glycoproteins of apparent molecular masses 103, 63, and 115 kD have been purified using virus-specific monoclonal antibodies (mAb) G8D1, C2D2, and T157, respectively. Both G8D1 and C2D2 neutralize HSV-I in vitro and passively protect CBA mice against HSV-I infection in vivo, whereas T157 is neither neutralizing nor passively protective. However, mice given a single subcutaneous injection of 30 micrograms 115 kD glycoprotein in saline were completely protected against lethal challenges of HSV-I administered intraperitoneally or in the footpad 7 d after immunization. In contrast, mice similarly immunized with 103 or 63 kD glycoproteins were only partially protected. The prophylactic immunity was correlated with an early induction of specific antibody, which became even more evident 3 d after virus challenge. There was a remarkable similarity in antibody isotype distribution between the responses to 115 kD glycoprotein and to heat-inactivated intact HSV-I. However, the prechallenge sera from 115 kD glycoprotein hyperimmunized mice were again neither virus-neutralizing nor passively protective. All three glycoproteins induced only low levels of delayed-type hypersensitivity (DTH). Pretreatment of mice with cyclophosphamide significantly enhanced DTH to 115 kD and 103 kD glycoproteins in the absence of antibody, but failed to confer significant immunity, indicating that DTH alone is insufficient for protection. Splenic and lymph node Ig- (B cell-depleted) cells from mice protectively immunized with 115 kD glycoprotein could adoptively transfer effective protection and enhance a virus neutralizing antibody response in normal recipients challenged with a lethal dose of HSV-I. Both the protection and the ability to enhance neutralizing antibody were diminished when the cells were treated with mAb GK 1.5 and complement. These results therefore demonstrate that the 115 kD glycoprotein, though not apparently containing accessible epitopes for the induction of virus-neutralizing antibody, possesses determinants capable of activating helper T cells. These L3T4+ cells confer strong protective immunity by enhancing protective antibody upon challenge infection, probably through associative help.

Monoclonal antibodies to herpes simplex virus type 1 glycoproteins show that epitope location influences virus neutralization

Three monoclonal antibodies, G8D1 , C2D2 , and TI57 , reacting with herpes simplex virus type 1 glycoproteins have been characterised according to the location of their epitope and ability to neutralize infective virus. Immune electron microscopy and a blocking radioimmunoassay were used to locate the epitopes. The results indicate that the epitope recognised by G8D1 is located on the surface of the glycoprotein fringe, whereas those recognized by C2D2 and TI57 are interior with respect to this. Only G8D1 has neutralizing activity alone, whereas C2D2 can neutralize when antiglobulin is added. Thus, epitope location and density determine the neutralizing capacity of individual antibody molecules.